15 September 2015
Give your views on the adoption of new diabetes treatments and technologies
The Centre for the Advancement of Sustainable Medical Innovation (CASMI), a partnership between the University of Oxford and University College London, is conducting a pilot study to explore the cultural and organizational barriers to the adoption of innovation into the NHS. They are particularly interested in the interaction of NHS staff with clinician-academics and industry and are focusing on the adoption of new diabetic treatments and technologies in primary care.
This research will help inform understanding of the issues that have led to current failures in the translation of new technologies into affordable and widely adopted new treatments. The specific focus is to investigate the barriers and facilitators to working with other sectors on innovation adoption. The project is therefore focused on three groups who might work together: GPs and nurses in the primary health care sector; managers in the private sector and academic researchers in the universities.
The eventual aim is to develop a research programme that leads to implementable outcomes such as recommendations for change, training materials, networking policies or other ways to overcome the barriers identified.A series of qualitative interviews have already been conducted to understand this problem. From these results CASMI have developed ashort questionnaire for GPs, nurses, academics and industry professionals who work in diabetes care to fill in. The questionnaire asks for your opinions and experiences of innovation adoption and will taketo complete and will be anonymous for all participants.
